Produced by the Royal College of Physicians of Edinburgh and Royal College of Physicians and Surgeons of Glasgow

References

  1. Young CA. Improving the care of patients with progressive multiple sclerosis: an evidence-based approach. Proc R Coll Physicians Edinb 2002;32:19-23.
  2. Wolinsky JS. The use of glatiramer acetate in the treatment of multiple sclerosis. Adv Neurol 2006;98:273-92.
  4. http://www.msdecisions.org.uk
  5. Goodin DS. Treatment of multiple sclerosis with human beta interferon. Int MS J 2005;12(3):96-108.
  6. Polman CH, O’Connor PW, Havrdova E et al;AFFIRM Investigators. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 200;354(9):899-910.
  7. Martinelli Boneschi F, Rovaris M et al. Mitoxantrone for multiple sclerosis. Cochrane Database Syst Rev 2005; (4):CD002127.
  8. Shakespeare DT, Boggild M, Young C. Anti-spasticity agents for multiple sclerosis. Cochrane Database Syst Rev 2003; (4):CD001332.
  9. Mills RJ, Yap L, Young CA. Treatment for Ataxia in Multiple Sclerosis (review). Cochrane Database Syst Rev 2007; (1):CD005029.